EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Effects of glucagon-like peptide-1 (GLP-1) mono-agonists on reward processing in animal models: a systematic review

Yang Jing Zheng iD, Hezekiah Ching Tin Au iD, Gia Han Le, Sabrina Wong, Kayla M Teopiz, Angela T H Kwan, Joshua D Rosenblat, Rodrigo B Mansur, Taeho Greg Rhee, Heidi Ka Ying Lo, Roger S McIntyre iD

Acta Neuropsychiatrica · 2026

DOI: 10.1017/neu.2026.10097 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Acta Neuropsychiatrica, 2026. Verfasst von Yang Jing Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Sciences, University of Toronto, Canada. Hauptthemen laut MEDLINE: Reward, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptide 1, Behavior, Animal. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Glucagon-like peptide-1 (GLP-1), indicated in the treatment of type 2 diabetes mellitus, influences reward processing, integral to disparate mental disorders. Emerging evidence suggests that GLP-1 receptor mono-agonists (GLP-1RAs) are potential treatment strategies for select mental disorders. Herein, we systematically review preclinical research documenting how GLP-1 and GLP-1RAs may impact reward function.

Methods

Relevant studies were identified through Web of Science, OVID (MedLINE, Embase, PsycInfo), and PubMed from database inception to June 28, 2026. Preclinical research investigating the association between GLP-1 and select GLP-1RAs and reward function was included. Reward functions assessed were food-, drug-, and sexual-related reward.

Results

A total of 66 studies met inclusion and were synthesised herein. Taken together, results indicate that GLP-1 and GLP-1RAs affect measures of food-related, drug-associated, and sexual behaviours. GLP-1 administration was associated with a reduction in food intake and gross locomotor activity with respect to approaching and engaging in reward-seeking behaviours. When locally administered in selected brain regions of evaluated animal models, exenatide was associated with reduced substance use, food seeking, and sexual behaviours ( p < 0.05). Similarly, liraglutide was observed to attenuate substance and food-related rewards ( p < 0.05). In addition, semaglutide was demonstrated to reduce substance and sucrose intake, while dulaglutide is reported to reduce substance intake ( p < 0.001).

Discussion

Extant preclinical findings demonstrate a trend toward reductions in reward-associated behaviours following GLP-1RA administration. Our findings can also provide rationale and impetus for evaluating GLP-1RAs in the treatment of psychiatric disorders characterised by disturbance in hedonic function and behaviours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RewardGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide 1Behavior, AnimalAnimalsExenatideSemaglutideLiraglutideDisease Models, AnimalHumansGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

exenatideglucagon-like peptide 1 receptor agonistliraglutidereward functionssemaglutide

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsExenatideSemaglutideGlucagon-Like Peptide 1LiraglutideGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Institute of Medical Sciences, University of Toronto, Canada.
  • Brain and Cognition Discovery Foundation, Canada.
  • Department of Pharmacology and Toxicology, University of Toronto, Canada.
  • Faculty of Medicine, University of Ottawa, Canada.
  • University Health Network, Canada.
  • Department of Psychiatry, Yale School of Medicine, USA.

ORCID-Profile: Yang Jing Zheng, Hezekiah Ching Tin Au, Roger S McIntyre

Zitieren

APA

Zheng, Y. J., Au, H. C. T., Le, G. H., Wong, S., Teopiz, K. M., Kwan, A. T. H., Rosenblat, J. D., Mansur, R. B., Rhee, T. G., Lo, H. K. Y., & McIntyre, R. S. (2026). Effects of glucagon-like peptide-1 (GLP-1) mono-agonists on reward processing in animal models: a systematic review. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2026.10097

Vancouver

Zheng YJ, Au HCT, Le GH, Wong S, Teopiz KM, Kwan ATH, et al. Effects of glucagon-like peptide-1 (GLP-1) mono-agonists on reward processing in animal models: a systematic review. Acta Neuropsychiatrica. 2026. doi:10.1017/neu.2026.10097

BibTeX
@article{Zheng2026,
  author = {Zheng, Yang Jing and Au, Hezekiah Ching Tin and Le, Gia Han and Wong, Sabrina and Teopiz, Kayla M and Kwan, Angela T H and Rosenblat, Joshua D and Mansur, Rodrigo B and Rhee, Taeho Greg and Lo, Heidi Ka Ying and McIntyre, Roger S},
  title = {Effects of glucagon-like peptide-1 (GLP-1) mono-agonists on reward processing in animal models: a systematic review},
  journal = {Acta Neuropsychiatrica},
  year = {2026},
  doi = {10.1017/neu.2026.10097}
}
Kostenlos starten →